US-based monitoring solutions provider Edwards Lifesciences has purchased Harpoon Medical for a cash consideration of $100m.

Under the merger agreement, Harpoon is further eligible for up to $150m in pre-specified milestone payments over the coming ten years.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Harpoon Medical focuses on developing beating-heart repair solutions for degenerative mitral regurgitation (DMR).

The firm has designed a system for echo-guided repair of the valve regurgitation through stabilisation of the prolapsed mitral valve leaflet, restoring normal coaptation and valve function.

It is expected that the device could aid therapy during a minimally invasive beating-heart procedure, paving way for early treatment, quick recovery, less morbidity and consistent patient outcomes.

“The investigational system is intended to support Edwards’ structural heart disease treatments and is set to obtain CE-Mark in the near future.”

The investigational system is intended to support Edwards’ structural heart disease treatments and is set to obtain CE-Mark in the near future.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Edwards Lifesciences surgical heart valve therapy corporate vice-president Bernard Zovighian said: “We believe the addition of Harpoon Medical’s technology and talented team will enable even more opportunities to help patients with degenerative mitral regurgitation.

“The unique beating-heart repair procedure for mitral valve patients complements Edwards’ comprehensive portfolio of treatments for structural heart disease, and reinforces our commitment to innovation in cardiac surgery.”

Along with patient-focused solutions for structural heart disease, the firm develops critical care and surgical monitoring devices.

Through partnerships with various clinicians and researchers, the firm works towards addressing unmet healthcare needs with better patient outcomes and quality of life.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact